These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30614924)

  • 1. APPLICATION OF ADJUNCTIVE TOPICAL MITOMYCIN-C IN SCLEROSTOMY REVISION FOR REFRACTORY IDIOPATHIC UVEAL EFFUSION SYNDROME.
    Zhu I; Haq Z; Ali MH; Chang PY; Zahid S; Mieler WF
    Retin Cases Brief Rep; 2021 Jul; 15(4):339-343. PubMed ID: 30614924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of serous retinal detachment following partial sclerectomy with mitomycin C in nanophthalmos.
    Venkatesh P; Majumdar SS; Kakkar A; Singh S; Gogia V; Garg S
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(3):287-9. PubMed ID: 23676234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanophthalmic uveal effusion managed with scleral windows and topical mitomycin-C.
    Akduman L; Adelberg DA; Del Priore LV
    Ophthalmic Surg Lasers; 1997 Apr; 28(4):325-7. PubMed ID: 9101574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleral window surgery and topical mitomycin C for nanophthalmic uveal effusion complicated by renal failure: case report.
    Suzuki Y; Nishina S; Azuma N
    Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):755-7. PubMed ID: 17024441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanophthalmic uveal effusion.
    Allen KM; Meyers SM; Zegarra H
    Retina; 1988; 8(2):145-7. PubMed ID: 3047825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retrospective Case Series of Uveal Effusion Syndrome.
    Claeys E; Stalmans P; Van Calster J; Casteels I; Stalmans I; Vandewalle E
    J Glaucoma; 2020 Oct; 29(10):995-998. PubMed ID: 32769728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleral punch method with topical mitomycin C for safe revision of failed deep sclerectomy in nanophthalmic uveal effusion syndrome.
    Sabrosa NA; Smith HB; MacLaren RE
    Graefes Arch Clin Exp Ophthalmol; 2009 Jul; 247(7):999-1001. PubMed ID: 19130073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive circumferential partial-thickness sclerectomy in eyes with extreme nanophthalmos and spontaneous uveal effusion.
    Mansour A; Stewart MW; Shields CL; Hamam R; Abdul Fattah M; Sheheitli H; Mehanna CJ; Yassine S; Chahine H; Keaik M; Maalouf F; Jaroudi M
    Br J Ophthalmol; 2019 Dec; 103(12):1862-1867. PubMed ID: 30877130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveal effusion syndrome: a case report.
    Hodges B; Omoruyi F; Allison K
    J Med Case Rep; 2024 Mar; 18(1):169. PubMed ID: 38509616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the Results of Vitrectomy and Sclerectomy in a Patient with Nanophthalmic Uveal Effusion Syndrome.
    Popov I; Popova V; Krasnik V
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33572746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uveal Effusion Associated with Presumed Viral Encephalitis.
    Lee DH; Kim TY; Lee SC; Kim M
    Ocul Immunol Inflamm; 2022 Jan; 30(1):68-72. PubMed ID: 32816570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid resolution of severe exudation in uveal effusion syndrome with anti-vascular endothelial growth factor alone in a case of bilateral nanophthalmos: a case report.
    Song L; Dong F; Yi C
    J Med Case Rep; 2021 Oct; 15(1):515. PubMed ID: 34663453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uveal effusion syndrome – a case study].
    Grabska-Liberek I; Zagajewska K; Kosmala J
    Klin Oczna; 2016; 118(3):238-40. PubMed ID: 30088390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified ultrasound-guided surgical technique for the management of the uveal effusion syndrome in patients with normal axial length and scleral thickness.
    Ghazi NG; Richards CP; Abazari A
    Retina; 2013 Jun; 33(6):1211-9. PubMed ID: 23503341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal imaging to aid in diagnosis of uveal effusion syndrome type 3.
    Markan A; Moharana B; Dogra M; Singh R
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33653850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical brimonidine induced acute uveal effusion in a patient with nanophthalmos: a case report.
    Li Y; Zhou Q
    BMC Ophthalmol; 2023 Oct; 23(1):405. PubMed ID: 37814274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UVEAL EFFUSION SYNDROME. CASE REPORT.
    Konrád A; Penčák M; Veith M; Studený P
    Cesk Slov Oftalmol; 2021; 77(4):202-206. PubMed ID: 34507496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveal Effusion Syndrome: Clinical Characteristics, Outcome of Surgical Treatment, and Histopathological Examination of the Sclera.
    Zhou N; Yang L; Xu X; Wei W
    Front Med (Lausanne); 2022; 9():785444. PubMed ID: 35755052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choroidal findings in idiopathic uveal effusion syndrome.
    Harada T; Machida S; Fujiwara T; Nishida Y; Kurosaka D
    Clin Ophthalmol; 2011; 5():1599-601. PubMed ID: 22140304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fundus autofluorescence and spectral-domain optical coherence tomography findings of leopard spots in nanophthalmic uveal effusion syndrome.
    Okuda T; Higashide T; Wakabayashi Y; Nishimura A; Sugiyama K
    Graefes Arch Clin Exp Ophthalmol; 2010 Aug; 248(8):1199-202. PubMed ID: 20300765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.